FTNet, the startup that owns Fdirect, a B2B digital ecosystem dedicated to the pharmaceutical distribution market, announces the closure of its third round of investment with the collection of €4 million from private investors, bringing the total amount raised since the company’s inception to €10 million.
The funds raised will be used to accelerate the development of the Fdirect platform and further boost the company’s growth through commercial expansion and a focus on new strategic markets. Stefano Beltrame, co-founder of FTNet with Marco Di Tonto, (pictured with the team) said in a statement: “The timing and manner in which we closed this third round represents a milestone that makes us extremely proud and confirms the value of our project. full alignment in strategic vision with our investors and their complete confidence in the business model and all members of our dream team, confidence that is fully fuelled by the excellent performance achieved by the platform in just two years since its launch on 25 April 2023. We thank all our investors for the constant and unwavering support they show us every day.
Thanks to the support of investors, Fdirect has decided to promote the FIDES project, an economically sustainable Italian digital pharmacy, aimed at ensuring greater sustainability for small and medium-sized pharmacies in Italy. FIDES, created to enhance and serve in a sustainable manner the 40% of Italian pharmacies that are often excluded from direct commercial circuits, despite the unique role they play in the distribution model, is a concrete project that allows the three players in the market, pharmacies, pharmaceutical companies and intermediate distributors, to establish a more efficient and effective relationship in the digital environment. This project will enable local pharmacies to benefit from the intrinsic value of the commercial relationships they can establish with specific pharmaceutical companies.
“These pharmacies represent a segment that, due to the size of their turnover or purely logistical issues, does not receive the attention it deserves in the go-to-market practices of top industries. Yet, even here, there is still significant untapped commercial growth potential,” says Di Tonto. Pharmaceutical companies, in turn, with the collaboration of those intermediate distributors who have joined the FIDES project, will be able to establish valuable commercial relationships with small and medium-sized pharmacies throughout the country, promoting the development of quality commercial relationships and optimising last-mile delivery, which can be carried out by the intermediate distributors participating in the initiative. Being able to sustainably control this market segment will unlock incremental value for the entire supply chain, including the Intermediate Distributor, which will be able to capture additional revenue.
With this project, Fdirect aims to offer industry and intermediate distributors a sustainable, scalable, and technologically advanced channel for generating profitable relationships without disrupting the existing distribution architecture. FIDES allows for the optimisation of target pharmacies, ensuring distribution coverage with quality sales. The project’s operating model will be entirely coordinated by Fdirect as a third party and therefore free from conflicts of interest with respect to the three players involved in B2B pharmaceutical distribution: from communication activities (social media, press, digital) to pharmacy onboarding, training and ongoing post-activation support.
ALL RIGHTS RESERVED ©